InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,258.80
(
0.00%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
84.76
(
-0.29%
)
Bitcoin
64,250.02
(
-0.88%
)
Post# of 11381
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

kevindenver

Send PM Follow Ignore
Followers 69
Posts 7598
Boards Moderated 0
Alias Born 01/10/2014

kevindenver

Re: Citrati post# 11156

Tuesday, 12/19/2023 2:20:00 PM

Tuesday, December 19, 2023 2:20:00 PM

Post# of 11381
I think Anavex will take a licensing approach to AD, PD/PDD and keep rare diseases in house. Same thoughts I had 8 years ago.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up